Navigation Links
Updated Abbott Statement: To Help Respond to Growing Health Crisis, Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts
Date:1/18/2010

ABBOTT PARK, Ill., Jan. 18 /PRNewswire-FirstCall/ -- Working directly with humanitarian partners to help address the growing health care crisis, Abbott (NYSE: ABT) is expanding its support for relief efforts in Haiti.  The company will provide $2.5 million in grant funding and donations of critical pharmaceutical and nutritional products to humanitarian aid organizations.  

An initial quantity of Abbott pharmaceutical and nutritional products are already in use in several locations in Haiti as a result of prior work with Direct Relief International to strategically pre-position essential health care products in preparation for potential natural disasters.  These products include antibiotics, rehydration solutions and additional nutritional products that are in critical need following the earthquake in Haiti.  Abbott will continue to work with relief partners to assess and respond to ongoing needs for longer-term recovery efforts.

Video of Abbott products being packed by Direct Relief International for use in Haiti is available at http://agendanyc.com/clients/abbott/preparedness.htm.  Shot in mid-2009, this footage highlights ongoing efforts to pre-position aid.

Background on Abbott's Existing Philanthropic Work in
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Issues Updated Financial And Operational Information
2. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
3. AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
4. Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting
5. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
6. Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
7. New and Updated Online Tutorials for PROSITE, InterPro, IntAct and UniProt
8. New and Updated Online Tutorials for Textpresso and Gene Ontology
9. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
10. StollerUSA Launches Updated Web site For Growers and Farmers
11. Updated Online Tutorials for DBTSS, Pfam and PDB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , Md. and BALTIMORE , May ... (BHI), a regional private-public partnership focusing on commercializing ... funding in Central Maryland , ... M.B.A., as the first Entrepreneur-in-Residence (EIR) for BHI ... National Heart, Lung and Blood Institute (NHLBI). ...
(Date:5/20/2013)... May 20, 2013 Rhythm announced today the ... RM-131, the company,s novel ghrelin agonist for the treatment ... trial demonstrated that RM-131 significantly accelerates early gastric emptying ... diabetic patients with diabetic gastroparesis. The findings were presented ... Orlando and recently published in ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recognizing ... young faculty members to its 2013 Class of ... the company will provide this outstanding international group ... in advancing basic science to meet global challenges.     ... to help promising young and untenured research faculty ...
(Date:5/20/2013)... 2013 In Early 2013, Dr. ... biotoxin related illnesses , announced his vision for creating ... advance his protocol for treating Chronic Inflammatory Response Syndrome ... physician to achieve certification in the Shoemaker Protocol. ... practice the Shoemaker Protocol in other parts of the ...
Breaking Biology Technology:BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2
... May 23, 2012 Reportlinker.com announces ... is available in its catalogue: ... to 2018 - Novel Oral JAK ... Drugs (DMARD) Will Drive Continued Growth ...
... Oxford, May 22, 2012 - Researchers in Ireland have ... glasses to produce high-precision molds for making tiny plastic ... be used in the next generation of computer memory ... In their article published in the latest edition of ...
... 2012   GeneLink, Inc. (OTCBB: GNLK.OB, "the ... financial results for the three months ended March 31, 2012. ... February 10, 2012 the Company closed on the sale of ... transaction entered into in October 2011. The sale price was ...
Cached Biology Technology:Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 2Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 3Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 4Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 5Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 6Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 7Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 8Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 9Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 10Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 11Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications 12Making microscopic machines using metallic glass 2GeneLink Reports First Quarter 2012 Financial Results 2
(Date:5/17/2013)... An international team of scientists using a new ... inside a living frog embryo in greater detail than ... advance biological research and the search for new treatments ... Karlsruher Institut fr Technologie in Germany, in collaboration with ... Energy,s Argonne National Laboratory, released the most precise depiction ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... living closer to a fast food restaurant had a ... further away from fast food, according to researchers at ... this association was particularly strong among those with a ... in the American Journal of Public Health ... fast food restaurant, and among lower-income African-Americans, the density, ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... 2011) Researchers looking to find a root cause for ... a novel investigative approach that borders on science fiction as ... the nation,s No. 1 killer. The National Institutes of ... Scripps Translational Science Institute (STSI) of San Diego and Sangamo ...
... wide variety of new cut flower cultivars and species ... University and the Association of Specialty Cut Flower Growers. ... United States and Canada, provides valuable production and marketing ... team from North Carolina State University undertook a multiyear ...
... Stephane Len, both researchers at the IRMES (Institut de ... France), have published their findings in Age , ... the evolution of performances in elite athletes and chess ... developed by the laboratory, and suggests that changes in ...
Cached Biology News:Scripps awarded $7.9 million NIH grant for research to find root cause of heart attack 2Scripps awarded $7.9 million NIH grant for research to find root cause of heart attack 3Scripps awarded $7.9 million NIH grant for research to find root cause of heart attack 4Extending the vase life of cut flowers: Pre-treatments and preservatives studied 2Evolution of sport performances follows a physiological law 2
Alexa Fluor 647 anti-mouse Qa-2...
Mouse monoclonal [0.T.81] to Lac1 ( Abpromise for all tested applications). Antigen: Recombinant TrpE fusion protein containing full length E. coli Lac1....
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
3T3 cells (RSV-transformed) Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: